The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

High-dose vitamin D added to chemotherapy failed to provide a benefit in patients with metastatic colorectal cancer in the ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.

The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for ...

Inspired by Pfizer’s response to the COVID pandemic, Miguel Agreda ’25 brought his skills as a joint-degree MBA/MPH student ...

Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...

Pfizer Inc has launched the company’s first ever dedicated commercial analytics centre in India called, the ‘Analytics ...

New treatment builds on Pfizer’s migraine portfolio to further meet the needs of people living with this debilitating disease ...